France Launches Public Debate on Nanotechnology
Summary posted by Meridian on 10/1/2009
Source: Nanovip
Author: n/a
The Commission of Public Debates (CPDP) in France will lead a series of public meetings throughout the country in an effort to involve the public in the debate over nanotechnology. Seventeen public meetings, each organized around a different theme, yet related to the region in which the debate takes place, will be held, with the first occurring in Strasbourg on October 15, 2009, and the last in Paris on February 23, 2010. Jean Bergougnoux, president of the CPDP, says the debates bring the views of the public to those in decision making roles: "[T]his debate must inform the public on the complex problems related to nanotechnology, allow the public to put forward their concerns and expectations, and make decision makers aware of their responsibilities." The debate program is supported by a website where interested parties can learn more about nanotechnology and follow the dialogue of the public meetings. The article, as well as a link to the debate website, can be found online at the link below.
The original article may still be available at www.nanovip.com/home/1129-france-launches-public-debate-on-nanotechnology
As tagged by Meridian Institute:
Implications:
Human Enhancement, Human Health Risks, Worker Safety, Governance, Environmental Risks, Ethics
Materials And Manufacturing:
Manufacturing, Materials
Regions:
Europe
Stakeholders:
Government
Related Forums:
3rd International Seminar on Nanosciences and Nanotechnology
-- Seminario Naotecnologias Cuba (7/29/2010) The 3rd International Seminar on Nanosciences and Nanotechnology, organized by the Office of the Scientific Advisor to the State Council of the Republic of Cuba and the Center for Advanced Cuban Studes (CEAC), will take place from September 6-10, 2010, in Havana, Cuba. The aim of the conference is to open new paths of cooperation for the development of CEAC, consolidate existent and emerging networks in the country, and provide elements for the design of a national strategy in this field. [More]
Super-sizing a Cancer Drug Minimizes Side Effects
-- MIT News (7/29/2010) Scientists at the Harvard-MIT Division of Health Sciences and Technology (HST) have designed a new version of the drug cisplatin, one of the first chemotherapy drugs given to patients diagnosed with cancer, that spares the kidneys, allowing doctors to use higher doses. [More]
An Asphalt Pact Cut Fumes—& Created A Model
-- New Haven Independent (7/29/2010) At a recent conference hosted by the United States National Institute for Occupational Safety and Health (NIOSH), convened to talk about the potential health hazards in the nanotechnology industry, a successful partnership between government, industry, and workers to tackle worker safety in the asphalt industry was looked to as a possible model for addressing worker safety in the nanotechnology industry. [More]
Nanomagnets Remove Pathogens from Blood
-- Nanowerk (7/28/2010) Researchers from the Institute for Chemical and Bioengineering of the ETH Zurich, Switzerland, have demonstrated a novel use of nanomagnets to rapidly and selectively remove heavy metal ions, overdosed steroid drugs and proteins from human blood. [More]
Learn how to include these headlines on your own website by clicking here.
Please email us if you require text-only versions of the daily emails.
